NewsAstraZeneca stock dives 9% after heart drug trial misses target Posted on July 9, 2026 by budd87309@gmail.com A late-stage clinical trial failed to miss its primary endpoint, U.K.’s laregst drugmaker said Thursday. budd87309@gmail.com From ‘dear Donald’ to ‘Trump trillion’: Inside NATO chief Mark Rutte’s U.S. strategy PepsiCo earnings miss estimates as North American consumers tighten their budgets
